JPRAS open · 2026
Biodegradable temporizing matrix in the management of exposed cortical bone without periosteum: a flap-sparing and reproducible strategy.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tobalem Benjamin, Ungerer Lucas, Ferrero Lauren, Bissar Jad, Bouaziz Salomon, Chaouat Marc, Boccara David, Serror Kevin
Аннотация
BACKGROUND: Exposure of cortical bone without periosteum (CBWP) represent a complex wound with poor healing potential, regardless of its location. Coverage traditionally relies on flaps, a complex reconstruction procedure. The use of a synthetic biodegradable dermal matrix (Novosorb® BTM) may promote formation of a vascularized neodermis over cortical bone, allowing subsequent skin grafting or secondary healing. This study aims to evaluate the effectiveness and limitations of synthetic dermal matrix in covering CBWP, potentially redefining flap indications.
METHODS: We conducted a retrospective single-center study including consecutive patients presenting CBWP exposure, regardless of etiology or anatomical site, over a one-year period. Management followed a standardized staged protocol: Surgical debridement ± cortical bone preparation, secure application of Novosorb®, delamination upon homogeneous neodermis formation, followed by split-thickness skin grafting (STSG) or secondary epithelialization. Primary outcomes were complete epithelialization and time-to-event.
RESULTS: 19 patients with 22 defects (scalp n = 14, face n = 2, tibia n = 5, chest wall n = 1) were treated with this protocol. Complete healing was achieved in 17 cases (10 by secondary epithelialization, 7 by STSG). Median time to grafting readiness was 37.5 days, and median time to complete healing was 65 days. We identified major complication rate in 4 (flap conversion in 2), and minor complications in 2 cases. At 6 months, all successfully treated wounds remained stable with satisfying functional and aesthetic outcomes.
CONCLUSIONS: A staged synthetic dermal matrix (Novosorb® BTM) protocol reliably converts CBWP into a vascularized wound bed suitable for STSG or secondary epithelialization, by promoting neovascularization and granulation tissue formation. It offers temporal predictability and reduces the need for flap reconstruction in selected complex cases.
LEVEL OF EVIDENCE: IV.
METHODS: We conducted a retrospective single-center study including consecutive patients presenting CBWP exposure, regardless of etiology or anatomical site, over a one-year period. Management followed a standardized staged protocol: Surgical debridement ± cortical bone preparation, secure application of Novosorb®, delamination upon homogeneous neodermis formation, followed by split-thickness skin grafting (STSG) or secondary epithelialization. Primary outcomes were complete epithelialization and time-to-event.
RESULTS: 19 patients with 22 defects (scalp n = 14, face n = 2, tibia n = 5, chest wall n = 1) were treated with this protocol. Complete healing was achieved in 17 cases (10 by secondary epithelialization, 7 by STSG). Median time to grafting readiness was 37.5 days, and median time to complete healing was 65 days. We identified major complication rate in 4 (flap conversion in 2), and minor complications in 2 cases. At 6 months, all successfully treated wounds remained stable with satisfying functional and aesthetic outcomes.
CONCLUSIONS: A staged synthetic dermal matrix (Novosorb® BTM) protocol reliably converts CBWP into a vascularized wound bed suitable for STSG or secondary epithelialization, by promoting neovascularization and granulation tissue formation. It offers temporal predictability and reduces the need for flap reconstruction in selected complex cases.
LEVEL OF EVIDENCE: IV.